AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionKendall Capital Management
Latest Disclosed Ownership24,945 shares
Latest Disclosed Value $ 5,425,288
Kendall Capital Management reports 0.11% increase in ownership of 4AB / AbbVie Inc.

On April 24, 2026 - Kendall Capital Management filed a 13F-HR form disclosing ownership of 24,945 shares of AbbVie Inc. (BG:4AB) valued at $5,425,288 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 24,918 shares of AbbVie Inc.. This represents a change in shares of 0.11% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F Abbvie COM 00287Y109 24,945 27 0.11 5,425 -4.71 1.1118
2026-01-16 2025-12-31 13F Abbvie COM 00287Y109 24,918 -1,324 -5.05 5,694 -6.30 1.1910
2025-11-13 2025-09-30 13F Abbvie COM 00287Y109 26,242 -722 -2.68 6,076 21.40 1.3698
2025-07-16 2025-06-30 13F Abbvie COM 00287Y109 26,964 -626 -2.27 5,005 -13.41 1.3237
2025-04-25 2025-03-31 13F Abbvie COM 00287Y109 27,590 -2,557 -8.48 5,781 7.90 1.6985
2025-02-07 2024-12-31 13F Abbvie COM 00287Y109 30,147 -1,905 -5.94 5,357 -15.36 1.5675
2024-11-08 2024-09-30 13F Abbvie COM 00287Y109 32,052 -675 -2.06 6,330 12.76 1.9542
2024-08-12 2024-06-30 13F Abbvie COM 00287Y109 32,727 -126 -0.38 5,613 -6.17 1.8716
2024-05-10 2024-03-31 13F Abbvie COM 00287Y109 32,853 -615 -1.84 5,983 15.35 2.0582
2024-01-26 2023-12-31 13F Abbvie COM 00287Y109 33,468 1,033 3.18 5,187 129,550.00 2.0147
2023-10-31 2023-09-30 13F Abbvie COM 00287Y109 32,435 195 0.60 5 0.00 2.1434
2023-07-28 2023-06-30 13F Abbvie COM 00287Y109 32,240 731 2.32 4 -20.00 1.9040
2023-05-11 2023-03-31 13F Abbvie COM 00287Y109 31,509 347 1.11 5 0.00 2.4128
2023-01-30 2022-12-31 13F Abbvie COM 00287Y109 31,162 -947 -2.95 5 -99.88 2.5446
2022-11-02 2022-09-30 13F Abbvie COM 00287Y109 32,109 -370 -1.14 4,309 -13.37 2.5074
2022-07-29 2022-06-30 13F Abbvie COM 00287Y109 32,479 -845 -2.54 4,974 -7.92 2.7394
2022-05-06 2022-03-31 13F Abbvie COM 00287Y109 33,324 -1,815 -5.17 5,402 13.54 2.6109
2022-01-28 2021-12-31 13F Abbvie COM 00287Y109 35,139 -796 -2.22 4,758 22.76 2.2586
2021-11-05 2021-09-30 13F Abbvie COM 00287Y109 35,935 -930 -2.52 3,876 -6.65 2.0957
2021-07-30 2021-06-30 13F Abbvie COM 00287Y109 36,865 -635 -1.69 4,152 2.32 2.3344
2021-05-05 2021-03-31 13F Abbvie COM 00287Y109 37,500 310 0.83 4,058 1.83 2.5108
2021-02-08 2020-12-31 13F Abbvie COM 00287Y109 37,190 -335 -0.89 3,985 21.24 2.9067
2020-10-22 2020-09-30 13F Abbvie COM 00287Y109 37,525 870 2.37 3,287 -8.67 2.8592
2020-07-30 2020-06-30 13F Abbvie COM 00287Y109 36,655 3,575 10.81 3,599 42.82 3.4468
2020-04-27 2020-03-31 13F Abbvie COM 00287Y109 33,080 -2,906 -8.08 2,520 -20.90 2.8515
2020-01-24 2019-12-31 13F Abbvie COM 00287Y109 35,986 1,022 2.92 3,186 20.36 2.5077
2019-11-12 2019-09-30 13F Abbvie COM 00287Y109 34,964 2,570 7.93 2,647 12.35 2.3391
2019-08-09 2019-06-30 13F Abbvie COM 00287Y109 32,394 878 2.79 2,356 -7.24 2.1312
2019-05-08 2019-03-31 13F Abbvie COM 00287Y109 31,516 1,345 4.46 2,540 -8.67 2.4077
2019-02-13 2018-12-31 13F Abbvie COM 00287Y109 30,171 -483 -1.58 2,781 -4.07 2.8798
2018-10-29 2018-09-30 13F Abbvie COM 00287Y109 30,654 1,963 6.84 2,899 9.07 2.4679
2018-07-27 2018-06-30 13F Abbvie COM 00287Y109 28,691 965 3.48 2,658 1.30 2.3478
2018-05-14 2018-03-31 13F Abbvie COM 00287Y109 27,726 -85 -0.31 2,624 -2.45 2.2745
2018-02-14 2017-12-31 13F Abbvie COM 00287Y109 27,811 27,811 2,690 2.3882
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.